fbpx

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Deciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors

Deciphera Pharmaceuticals announced positive results from a phase 3 study of Repretinib in gastrointestinal stromal tumors.

Read Source
X